(Q68581827)
Statements
High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study (English)
Stebler C
Tichelli A
Dazzi H
Nissen C
1 December 1990